Vnitr Lek 2020, 66(3):e44-e48 | DOI: 10.36290/vnl.2020.059

Distant diabetes care: what can the patient, nurse and patient do

František Saudek, Klára Picková
Centrum diabetologie, Institut klinické a experimentální medicíny, Praha

Due to the spread of new coronavirus disease, COVID-19, social interactions between people have been significantly reduced. In healthcare, outpatient care is a high-risk frontline of infection transmission in both patients and healthcare professionals. The presence of routine digital communication, remote data management and the availability of glucose monitoring and insulin delivery devices have given diabetology a certain advantage in this situation. However, the potential of these modalities has not been fully utilized so far. We provide an overview of practical methods of distance patient management, which can be used in most diabetes outpatient clinics without any difficult adjustments or additional investments. This approach can be used in different patients according to their treatment strategies and individual abilities.

Keywords: COVID-19, diabetes, distanční péče, telemedicína, e-health.

Published: May 26, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Saudek F, Picková K. Distant diabetes care: what can the patient, nurse and patient do. Vnitr Lek. 2020;66(3):e44-48. doi: 10.36290/vnl.2020.059.
Download citation

References

  1. Zhu N, Zhang D, Wang W, et al. (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 382: 727-733. Go to original source... Go to PubMed...
  2. Wu Z, McGoogan JM (2020) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. Go to original source...
  3. Chen N, Zhou M, Dong X, et al. (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395: 507-513 Go to original source... Go to PubMed...
  4. Huang C, Wang Y, Li X, et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395: 497-506. Go to original source... Go to PubMed...
  5. Fadini GP, Morieri ML, Longato E, Avogaro A (2020) Prevalence and impact of diabetes among people infected with SARS‑CoV-2. J Endocrinol Invest. Go to original source... Go to PubMed...
  6. Guan WJ, Liang WH, Zhao Y, et al. (2020) Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J. Go to original source... Go to PubMed...
  7. společnost Čd Standardy a doporučení. Available from https://www.diab.cz/standardy
  8. Available from www.ikem.cz/cs/centrum‑diabetologie/edukacni‑materialy/a-3602
  9. (online) Čsú (2019) Používání mobilního telefonu a internetu na mobilním telefonu: Využívání informačních a komunikačních technologií v domácnostech a mezi jednotlivci. Available from https://www.czso.cz/csu/czso/5-komunikace‑na‑internetu
  10. Bergenstal RM, Beck RW, Close KL, et al. (2018) Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 41: 2275-2280. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.